Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 20 of 70 Results
Age
Type
Conditions or Disease:

PhI/II FirstInHuman Study DF9001 Comb w/Nivolumab Pa w/Solid Tumors Selected Indications

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

Evaluate Satralizumab as Monotherapy or in Addition to Baseline Therapy in Patients with MOGAD

Michael Sy

  • OPEN TO ACCRUAL

PhI/Ib FirstInHuman Investig SafeTolerabPharmBiologic&ClinicalActiv DF6215 Pa w/Adv Solid Tu

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

PhI Study PolymeraseThetaInhibitor Novobiocin BRCAMutant&Other DNADamageRepair-Deficient SolidTumors

Jennifer Brooke Valerin

  • OPEN TO ACCRUAL

Ph II Subcutan Amivantamab in Pts w/ Adv or Metastat SolidTumors EGFR-mutated Non-Small Cell Lung Ca

Misako Nagasaka

  • OPEN TO ACCRUAL

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

Tahseen Mozaffar

  • OPEN TO ACCRUAL

PhII NanO2TM Combo w/Rad&Temozolomide Pa w/NewlyDia GlioblsdtomaMultiforme: RESTORE

Xiao-Tang Kong

  • OPEN TO ACCRUAL

Double-Blind use of Staccato Alprazolam for participants with prolonged seizures

Lilit Mnatsakanyan

  • OPEN TO ACCRUAL

Advarra Reliance #26: Neuromuscular Observational Research (MOVR) Data Hub Protocol Pro00034893

Tahseen Mozaffar

  • OPEN TO ACCRUAL

PhI DoseEscalationExpandedCohort P-MUC1C-ALLO1 AdultSubjects AdvancedMeta SolidTumors

Rita Mehta

  • OPEN TO ACCRUAL

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Mona Sazgar

  • OPEN TO ACCRUAL

A Study to Evaluate PF-06823859 in People With Active Idiopathic Inflammatory Myopathies

Namita Goyal

  • OPEN TO ACCRUAL

PhII Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma

Daniela Bota

  • OPEN TO ACCRUAL

Venglustat on neuropathic and abdominal pain in male and female adults with Fabry disease

Changrui Xiao

  • OPEN TO ACCRUAL